GHCM
KYNB

Glen Harbor Capital Management’s Kyntra Bio KYNB Stock Holding History

Glen Harbor Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19
Closed -$26K – 1330
2019
Q1 		$26K Sell
19
-3
-14% -$4.07K ﹤0.01% 1261
2018
Q4 		$25K Buy
+22
New +$24.7K ﹤0.01% 1220

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Glen Harbor Capital Management's KYNB Position: Q2 2019 in Review

Glen Harbor Capital Management sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 19 shares — an estimated $26K sold.

Glen Harbor Capital Management first reported a position in KYNB in Q4 2018 and held it in 2 quarters. The position peaked at $26K in Q1 2019. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Glen Harbor Capital Management reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Glen Harbor Capital Management sold 19 Kyntra Bio shares in Q2 2019, an estimated $26K.
  • Glen Harbor Capital Management first reported a position in Kyntra Bio in Q4 2018 and held it in 2 quarters.
  • Glen Harbor Capital Management's Kyntra Bio position peaked at $26K in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Glen Harbor Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.